4don MSN
Influencer Sydney Towle Says 'Nothing Feels Real' After First Chemotherapy Treatment in Months
Sydney Towle, 26, has documented her journey with rare, aggressive bile duct cancer since she was diagnosed in 2023 ...
An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements. In the treatment of newly diagnosed biliary tract cancer, the current standard ...
When do you have tests for bile duct cancer? Bile duct cancer is also called cholangiocarcinoma. It is a rare type of cancer that develops in the bile ducts. Most people are diagnosed with bile duct ...
Adding liposome-encapsulated irinotecan to standard chemotherapy failed to improve survival as second-line treatment for advanced biliary cancer, a small randomized study showed. Median ...
Zanidatamab-hrii received FDA accelerated approval for HER2-positive biliary tract cancer, showing a 52% objective response rate in the HERIZON-BTC-01 trial. Biliary tract cancers represent 3% of ...
Sydney Towle has continued to speak about her mental health throughout treatment for her stage 4 cholangiocarcinoma ...
Biliary tract cancer (BTC), a rare malignancy that grows within the bile ducts and gallbladder, grows very aggressively. The fast progression associated with BTC makes it challenging to treat and ...
Biliary tract cancers, including cholangiocarcinoma and gallbladder carcinoma, represent a heterogeneous group of malignancies with rising global incidence and persistent dismal prognoses. Research in ...
FAMILIES HOPE. THESE WERE LITTLE CARICATURES THAT SARAH USED TO DRAW. IT’S A WAY TO KEEP HER CLOSE TO ME. DAVE FLEISCHER NEVER INTENDED TO BE AN ACTIVIST, BUT ALL THAT CHANGED WHEN HIS DAUGHTER GOT ...
A 25-year-old woman who’d been healthy and active until she suddenly developed bile duct cancer has written a final, poignant message announcing her death and urging people to “enjoy the little things ...
The FDA on Wednesday granted accelerated approval to zanidatamab (Ziihera), a bispecific antibody, for pretreated HER2-positive biliary tract cancer. Approval stipulates use in unresectable or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results